PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial
Abstract
Authors
D Altman J Choi R Elisei B Jarzab J Wadsley A Gilligan P Maeda S Bourke N Payakachat